Amgen, Kite Pharma Strike Deal

0

Thousand Oaks biotechnology company Amgen Inc. and Santa Monica cancer drug developer Kite Pharma Inc. announced today that they entered into a deal to develop and market cancer immunotherapies using Amgen’s cancer targets and Kite’s technology platform, Reuters reports. Read more about Kite Pharma’s recent endeavors in the Los Angeles Business Journal.

No posts to display